prijava
SARAJEVO, May 23 (FENA) - Bosnian pharmaceutical company ‘Bosnalijek’ has appointed retired US Army Major General David Grange as its Board of Directors Advisor.
As a part of international expansion plans, Bosnalijek’s CEO Nedim Uzunović elected Major General Grange (Ret.) as an advisor for his experience in working with major international pharma and biotech companies as well as his knowledge, network and business acumen to help further international business expansion plans of Bosnalijek as it grows and moves into the new markets.
Bosnalijek is an international company with successful operations in three continents, recognized in the region as the leader in pharmaceutical industry.
This significant step and reinforcement will result in strong positioning of its products and services in new markets with specific focus on out-licensing on the US Market and exports to Middle East and Africa.
“As the leading pharmaceutical company from Bosnia and Herzegovina, Bosnalijek is expanding to the new markets, with a special focus on the perspectives and opportunities of the USA market in offering out-licensing and manufacturing services to major US pharmaceutical companies as well as opening new markets in the Middle East and Africa for the exports of wide range of our portfolio produced here in BiH.
For this reason, the engagement of Major General David Grange, as a newly appointed advisor to Bosnalijek, will bring fresh perspective, experience, knowledge and contacts that will help us grow our business and expand into a large international business operation.
I am very grateful to the General Grange for accepting my invitation to join us and the opportunity to implement an idea I had for a long time to enlarge our team with the superior expert such as General Grange and help Bosnalijek towards new markets and business opportunities,” said Nedim Uzunović, CEO of Bosnalijek.
Major General Grange (Ret.) is known not only for his experience in the US Military but for his work in business, specifically pharmaceutical and clinical research field. Throughout his experience he served as the Chief Executive Officer of Pharmaceutical Product Development Inc., Chief Executive Officer of Pharm-Olam International, Ltd, and he has been Director of Tonix Pharmaceuticals Holding Corp. since February, 2018. Major General Grange also serves on other non-profit boards.
“I was impressed by Bosnalijek’s excellence, quality of work and business plans for international expansion on which I will work together with Nedim Uzunović to position Bosnalijek as a trustworthy partner to the leading international pharmaceutical companies both in the field of out-licensing as well as exports. I will use my experience and knowledge, as well as my networks to help Bosnalijek grow, as I support their efforts to expand into new markets,” commented Major General Grange upon his appointment as an Advisor to Bosnalijek.
Over the past ten years, Bosnalijek’s exports have increased three times with an average annual growth of 13 per cent. This result best represents the constant progress of Bosnalijek as a company committed to meeting needs of all its consumers, employees, shareholders and business partners.
The company’s vision is to step bravely into the new fields, investing in development of latest technology and solutions, knowledge, talent and youth, as well as to create new trends in the pharmaceutical industry in our region.
(FENA) S. R.
